LifeStance Health Group, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the Annual Meeting of Stockholders held by LifeStance Health Group, Inc. on June 2, 2026. The filing details the voting results for three proposals submitted to security holders.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting outcomes.
Material Changes and Voting Results
The following proposals were voted upon at the Annual Meeting:
- Proposal 1: Election of Directors
- David Bourdon: Elected with 244,968,319 votes For, 83,966,052 Withheld, and 29,782,714 Broker Non-Votes.
- Robert Bessler: Elected with 280,015,618 votes For, 48,918,753 Withheld, and 29,782,714 Broker Non-Votes.
- Proposal 2: Ratification of Independent Auditor
- PricewaterhouseCoopers LLP was ratified for the year ended December 31, 2026.
- Results: 357,756,707 For, 209,431 Against, 750,947 Abstain.
- Proposal 3: Advisory Vote on Executive Compensation
- Stockholders approved the named executive officer compensation on a non-binding basis.
- Results: 322,904,359 For, 5,675,861 Against, 354,151 Abstain, 29,782,714 Broker Non-Votes.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Confirm the total number of shares outstanding to calculate the percentage of votes cast for each proposal.
- Verify the specific terms of the three-year Class II director terms for David Bourdon and Robert Bessler.
- Review the full proxy statement for details on the executive compensation package approved in Proposal 3.
- Note the significant number of Broker Non-Votes (approx. 29.8 million) recorded for the director election and executive compensation proposals.